Can metformin stabilize PCSK9 level in stable coronary artery disease patients treated with statins?

INTRODUCTION: Proprotein convertase subtilisin/kexin type 9 (PCSK9) has emerged as an important marker of cardiovascular risk and a new target for therapeutic interventions. We aimed to study the influence of metformin on the level of circulating PCSK9 in patients with stable coronary artery disease...

Descripción completa

Detalles Bibliográficos
Autores principales: Shek, Aleksandr B., Alieva, Rano B., Kurbanov, Ravshanbek D., Hoshimov, Shavkat U., Nizamov, Ulugbek I., Ziyaeva, Adolat V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2019
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6704763/
https://www.ncbi.nlm.nih.gov/pubmed/31448346
http://dx.doi.org/10.5114/amsad.2019.86752

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6704763/
https://www.ncbi.nlm.nih.gov/pubmed/31448346
http://dx.doi.org/10.5114/amsad.2019.86752

Ejemplares similares